Role of dialysis technology in the removal of uremic toxins

被引:15
作者
Davenport, Andrew [1 ]
机构
[1] UCL, Sch Med, Royal Free Hosp, UCL Ctr Nephrol, London NW3 2PF, England
关键词
Azotemia; toxins; dialyzer membrane; hemadsorption; MASS-TRANSFER; FLOW-RATE; HEMODIALYSIS; MEMBRANE; FLUX; PHOSPHATE; KT/V; UREA;
D O I
10.1111/j.1542-4758.2011.00602.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Traditionally, the amount of hemodialysis prescribed for a patient has been based on urea clearance, as urea is not only retained in patients with chronic kidney disease, but also readily measurable, by reliable and inexpensive assays. More recently, other retained solutes, phosphate, beta(2) microglobulin, and latterly p-cresol have been reported to be associated with increased risk of mortality in hemodialysis patients. As such, developments in dialysis practice that would result in greater clearance of water-soluble middle-sized toxins and also protein-bound and/or organic solutes are being studied. Although session time is a key factor, switching from low flux to dialyzers with larger pores, the addition of convective transport with hemodiafiltration can help increase phosphate and beta(2) microglobulin clearances. Adsorption techniques can increase the clearance of organic and protein bound toxins either directly or indirectly by regenerating dialysate and ultrafiltrates.
引用
收藏
页码:S49 / S53
页数:5
相关论文
共 26 条
[1]   Effect of increasing dialysate flow rate on diffusive mass transfer of urea, phosphate and β2-microglobulin during clinical haemodialysis [J].
Bhimani, Jai P. ;
Ouseph, Rosemary ;
Ward, Richard A. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (12) :3990-3995
[2]   Serum β-2 microglobulin levels predict mortality in dialysis patients:: Results of the HEMO study [J].
Cheung, Alfred K. ;
Rocco, Michael V. ;
Yan, Guofen ;
Leypoldt, John K. ;
Levin, Nathan W. ;
Greene, Tom ;
Agodoa, Lawrence ;
Bailey, James ;
Beck, Gerald J. ;
Clark, William ;
Levey, Andrew S. ;
Ornt, Daniel B. ;
Schulman, Gerald ;
Schwab, Steven ;
Teehan, Brendan ;
Eknoyan, Garabed .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (02) :546-555
[3]   Determinants of uraemic toxin removal [J].
Clark, WR ;
Gao, DY .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 :30-34
[4]  
Davenport A, 2010, MINERVA UROL NEFROL, V62, P29
[5]   A wearable haemodialysis device for patients with end-stage renal failure: a pilot study [J].
Davenport, Andrew ;
Gura, Victor ;
Ronco, Claudio ;
Beizai, Masoud ;
Ezon, Carlos ;
Rambod, Edmond .
LANCET, 2007, 370 (9604) :2005-2010
[6]   Do Differences in Dialysis Prescription Impact on KDOQI Bone Mineral Targets? The Pan Thames Renal Audit [J].
Davenport, Andrew ;
Gardner, Carrie ;
Delaney, Michael .
BLOOD PURIFICATION, 2010, 30 (02) :111-117
[7]   Dialysis dose in acute kidney injury and chronic dialysis [J].
Davenport, Andrew ;
Farrington, Ken .
LANCET, 2010, 375 (9716) :705-706
[8]   The effect of dialysis modality on phosphate control : haemodialysis compared to haemodiafiltration. The Pan Thames Renal Audit [J].
Davenport, Andrew ;
Gardner, Carrie ;
Delaney, Michael .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (03) :897-901
[9]   Effect of the super-flux cellulose triacetate dialyser membrane on the removal of non-protein-bound and protein-bound uraemic solutes [J].
De Smet, Rita ;
Dhondt, Annemieke ;
Eloot, Sunny ;
Galli, Francesco ;
Waterloos, Marie Anne ;
Vanholder, Raymond .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (07) :2006-2012
[10]   Effect of dialysis dose and membrane flux in maintenance hemodialysis. [J].
Eknoyan, G ;
Beck, GJ ;
Cheung, AK ;
Daugirdas, JT ;
Greene, T ;
Kusek, JW ;
Allon, M ;
Bailey, J ;
Delmez, JA ;
Depner, TA ;
Dwyer, JT ;
Levey, AS ;
Levin, NW ;
Milford, E ;
Ornt, DB ;
Rocco, MV ;
Schulman, G ;
Schwab, SJ ;
Teehan, BP ;
Toto, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (25) :2010-2019